Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
81 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
KARL STORZ ENDOSCOPY BELGIUM from Sint-Agatha-Berchem, company number BE0454159542, closed financial year 2025 with a result of € 100,248 after tax. For that financial year KARL STORZ ENDOSCOPY BELGIUM recorded a gross margin of € 4 million and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 192,335 to € 100,248. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 1.1 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 100,248
▼ 48% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1 million.
People and assets in 2025
18.3
▲ 5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.7 million
▲ 64% vs 2024
€ 150,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 45,466
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 4 million
€ 1 million is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 774,281
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 921,196
▲ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 168,241 | € 113,622 | € 2,407,001 | € 3,960,125 | ▲ 65% |
| Profit after taxes | € 155 | € 16,313 | € 192,335 | € 100,248 | ▼ 48% |
| Equity | € 787,364 | € 803,677 | € 996,012 | € 1,096,260 | ▲ 10% |
| Total debts | € 51,737 | € 85,141 | € 7,597,532 | € 6,588,708 | ▼ 13% |
| Cash | € 652,303 | € 0 | - | - | |
| Retained profit | € 725,364 | € 741,677 | € 934,012 | € 1,034,260 | ▲ 11% |
| Bank debt | € 0 | € 0 | € 0 | € 4,000,000 | |
| Balance sheet total | € 839,101 | € 888,818 | € 8,593,544 | € 7,684,969 | ▼ 11% |
| Employees (FTE) | 1.5 | 1 | 13.3 | 18.3 | ▲ 5 |
Key figures of KARL STORZ ENDOSCOPY BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to KARL STORZ ENDOSCOPY BELGIUM?
What happened at KARL STORZ ENDOSCOPY BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- SEQUOIA 3 BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 100,248 (▼ 48% vs 2024). Source: NBB ↗
- SEQUOIA 3 BV became a director. NBB
- Maureen Huijgen became a director. NBB
- New establishment in Sint-Agatha-Berchem. KBO
- Start of the company according to the CBE. KBO
In short
From € 155 profit in 2022 to € 100,248 profit in 2025.
Paid € 154,391 in corporate taxes since 2022.
Best year ever: 2024, with € 192,335 profit.
On average € 216,400 of value added per employee in 2025.
A new publication or filing at KARL STORZ ENDOSCOPY BELGIUM? We notify you, reason included.
Follow KARL STORZ ENDOSCOPY BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind KARL STORZ ENDOSCOPY BELGIUM is Maureen Huijgen.
Directors
According to the 2025 annual accounts
Maureen Huijgen
Director
since 2018
Director · represented by Johan De Beukelaer
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Keizer Karellaan 584
1082 Sint-Agatha-Berchem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 81 companies are registered at this address.
All companies at this address →Accinauto
€ -930 gross margin · 2025
Boekhandel J. de Slegte-België
€ 492,460 gross margin · 2025
ATTENTIA, Erkend interprofessioneel Sociaal Secretariaat
€ 20.7 million revenue · 2025
Attentia Corporate
ATTENTIA Preventie & bescherming
€ 63.4 million revenue · 2025
+76 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0454.159.542
- VAT number
- BE 0454.159.542
- Registered office
- Keizer Karellaan 584, 1082 Sint-Agatha-Berchem
- Names & denominations
- KARL STORZ ENDOSCOPY BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 1994
- Peppol
- Active · Active since 24 Apr 2026
- Contact
- +3224848000
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten